Probiotic COVID trials

Summary

In this insightful presentation, Professor Paul Wishmeyer from Duke University School of Medicine discusses the pivotal role of probiotics in preventing and treating infections, including COVID-19. He presents evidence from clinical trials and meta-analyses that highlight probiotics' safety and efficacy in reducing infections and inflammation, emphasizing their potential to restore balance to the gut microbiome. Wishmeyer also introduces the PROTECT-HC trial, which explores the use of probiotics to prevent COVID-19 transmission within households, showcasing the promising future of probiotic interventions in healthcare.

The video is abnormal, and we are working hard to fix it.
Please replace the link and try again.

The video is abnormal, and we are working hard to fix it.
Please replace the link and try again.